The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies
Lehmann C, Heger L, Neubert K, Harzer C, Amon L, Yamazaki S, Heidkamp GF, Eissing N, Krug A, Leusen J, Ravetch J, Nimmerjahn F, Dudziak D (2017)
Publication Type: Conference contribution
Publication year: 2017
Journal
Book Volume: 15
Pages Range: 83-84
Authors with CRIS profile
Christian Lehmann
Department of Dermatology
Lukas Heger
Department of Dermatology
Christina Harzer
Professur für Immunologie
Lukas Amon
Department of Dermatology
Gordon Frederik Heidkamp
Department of Dermatology
Falk Nimmerjahn
Lehrstuhl für Genetik
Diana Dudziak
Professur für die Biologie Dendritischer Zellen
Involved external institutions
Ludwig-Maximilians-Universität (LMU)
Germany (DE)
Hokkaido University (Hokudai) / 北海道大学
Japan (JP)
University Medical Centre Utrecht (UMC Utrecht)
Netherlands (NL)
Rockefeller University
United States (USA) (US)
Germany (DE)
Hokkaido University (Hokudai) / 北海道大学
Japan (JP)
University Medical Centre Utrecht (UMC Utrecht)
Netherlands (NL)
Rockefeller University
United States (USA) (US)
How to cite
APA:
Lehmann, C., Heger, L., Neubert, K., Harzer, C., Amon, L., Yamazaki, S.,... Dudziak, D. (2017). The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies. (pp. 83-84).
MLA:
Lehmann, Christian, et al. "The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies." 2017. 83-84.
BibTeX: Download